From Americans For Safe Access
Dana Rohrabacher (R-CA) worked worked with ASA to draft the request after hearing about the continuing plight of medical cannabis patients and caregivers facing federal trial in California and elsewhere.
After pressure from the ASA office in D.C., the two principal co-sponsors of federal legislation to allow a medical defense in federal marijuana trials pushed for hearings on the bill before the end of the legislative session, but the measure failed to get through the House Judiciary Committee.
Reps. Sam Farr (D-CA) and Dana Rohrabacher (R-CA) worked with ASA to draft the request after hearing about the continuing plight of medical cannabis patients and caregivers facing federal trial in California and elsewhere.
The Truth in Trials Act (H.R. 3939), which has been introduced every session since 2003, would allow individuals facing federal prosecution for marijuana-related offenses to provide evidence at trial that their activities were legal under their state’s medical cannabis program.
Currently, federal defendants are barred from presenting evidence of medical conditions, doctors’ recommendations, or state law.
